Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Espinouse

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Blood|May 23, 1998
High CD34(+) cell counts decrease hematologic toxicity of autologous peripheral blood progenitor cell transplantationN Ketterer, G Salles, M Raba, et al.
Leukemia|October 15, 2005
Identification of a rare e8a2 BCR-ABL fusion gene in three novel chronic myeloid leukemia patients treated with imatinibJ M Cayuela, P Rousselot, F Nicolini, et al.
Bone Marrow Transplantation|November 20, 2002
Amifostine reduces mucosal damage after high-dose melphalan conditioning and autologous peripheral blood progenitor cell transplantation for patients with multiple myelomaC Thieblemont, C Dumontet, H Saad, et al.
European Journal of Cancer (Oxford, England : 1990)|January 18, 2012
A randomised phase II study of the efficacy, safety and cost-effectiveness of pegfilgrastim and filgrastim after autologous stem cell transplant for lymphoma and myeloma (PALM study)C Sebban, A Lefranc, L Perrier, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Blood|May 23, 1998
High CD34(+) cell counts decrease hematologic toxicity of autologous peripheral blood progenitor cell transplantationN Ketterer, G Salles, M Raba, et al.
Leukemia|October 15, 2005
Identification of a rare e8a2 BCR-ABL fusion gene in three novel chronic myeloid leukemia patients treated with imatinibJ M Cayuela, P Rousselot, F Nicolini, et al.
Bone Marrow Transplantation|November 20, 2002
Amifostine reduces mucosal damage after high-dose melphalan conditioning and autologous peripheral blood progenitor cell transplantation for patients with multiple myelomaC Thieblemont, C Dumontet, H Saad, et al.
European Journal of Cancer (Oxford, England : 1990)|January 18, 2012
A randomised phase II study of the efficacy, safety and cost-effectiveness of pegfilgrastim and filgrastim after autologous stem cell transplant for lymphoma and myeloma (PALM study)C Sebban, A Lefranc, L Perrier, et al.
Pageof 5